MARKET

KZIA

KZIA

Kazia Therapeuti
NASDAQ
13.25
-0.14
-1.05%
After Hours: 13.50 +0.25 +1.89% 19:59 07/02 EDT
OPEN
13.63
PREV CLOSE
13.39
HIGH
14.15
LOW
13.14
VOLUME
116.11K
TURNOVER
--
52 WEEK HIGH
17.40
52 WEEK LOW
4.860
MARKET CAP
151.41M
P/E (TTM)
-2.1840
1D
5D
1M
3M
1Y
5Y
1D
Kazia Therapeutics Price Target Announced at $34.00/Share by BTIG
Dow Jones · 4d ago
BTIG Initiates Coverage On Kazia Therapeutics with Buy Rating, Announces Price Target of $34
Benzinga · 4d ago
Kazia Therapeutics initiated with a Buy at BTIG
TipRanks · 4d ago
Weekly Report: what happened at KZIA last week (0622-0626)?
Weekly Report · 6d ago
Weekly Report: what happened at KZIA last week (0615-0619)?
Weekly Report · 06/22 09:09
Kazia Therapeutics CFO James Levine files initial beneficial ownership statement
PUBT · 06/15 22:53
Weekly Report: what happened at KZIA last week (0608-0612)?
Weekly Report · 06/15 09:08
ADRs Advance; 111 Inc. Climbs 14%
Dow Jones · 06/12 20:30
More
About KZIA
Kazia Therapeutics Limited is an Australia-based pharmaceutical drug development company. The Company operates in the pharmaceutical research and development business. The Company’s lead program is paxalisib, an investigational brain-penetrant inhibitor of the PI3K / Akt / mTOR pathway, which is being developed to treat multiple forms of brain cancer. It is also developing EVT801, a small-molecule inhibitor of VEGFR3, which is critical to the development of new blood vessels and lymphatic vessels in a growing tumor, as well as to the metastasis of tumors to distant sites in the body. It designed paxalisib to inhibit PI3K, a critical control mechanism in growth and cell division, which is activated in many forms of cancer. The Company’s drug candidates are designed to treat diseases, such as brain cancer, renal cancer, and liver cancer.

Webull offers Kazia Therapeutics Ltd (ADR) stock information, including NASDAQ: KZIA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KZIA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KZIA stock methods without spending real money on the virtual paper trading platform.